Correlation Between Unity Biotechnology and Elevation Oncology
Can any of the company-specific risk be diversified away by investing in both Unity Biotechnology and Elevation Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unity Biotechnology and Elevation Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unity Biotechnology and Elevation Oncology, you can compare the effects of market volatilities on Unity Biotechnology and Elevation Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unity Biotechnology with a short position of Elevation Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unity Biotechnology and Elevation Oncology.
Diversification Opportunities for Unity Biotechnology and Elevation Oncology
0.47 | Correlation Coefficient |
Very weak diversification
The 3 months correlation between Unity and Elevation is 0.47. Overlapping area represents the amount of risk that can be diversified away by holding Unity Biotechnology and Elevation Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Elevation Oncology and Unity Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unity Biotechnology are associated (or correlated) with Elevation Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Elevation Oncology has no effect on the direction of Unity Biotechnology i.e., Unity Biotechnology and Elevation Oncology go up and down completely randomly.
Pair Corralation between Unity Biotechnology and Elevation Oncology
Considering the 90-day investment horizon Unity Biotechnology is expected to under-perform the Elevation Oncology. But the stock apears to be less risky and, when comparing its historical volatility, Unity Biotechnology is 2.32 times less risky than Elevation Oncology. The stock trades about -0.04 of its potential returns per unit of risk. The Elevation Oncology is currently generating about 0.01 of returns per unit of risk over similar time horizon. If you would invest 151.00 in Elevation Oncology on August 28, 2024 and sell it today you would lose (90.00) from holding Elevation Oncology or give up 59.6% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unity Biotechnology vs. Elevation Oncology
Performance |
| Timeline |
| Unity Biotechnology |
| Elevation Oncology |
Unity Biotechnology and Elevation Oncology Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unity Biotechnology and Elevation Oncology
The main advantage of trading using opposite Unity Biotechnology and Elevation Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unity Biotechnology position performs unexpectedly, Elevation Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Elevation Oncology will offset losses from the drop in Elevation Oncology's long position.| Unity Biotechnology vs. Eliem Therapeutics | Unity Biotechnology vs. HCW Biologics | Unity Biotechnology vs. Scpharmaceuticals | Unity Biotechnology vs. Milestone Pharmaceuticals |
| Elevation Oncology vs. Eliem Therapeutics | Elevation Oncology vs. HCW Biologics | Elevation Oncology vs. Scpharmaceuticals | Elevation Oncology vs. Milestone Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |